Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $60,844 | 50 | 37.2% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $46,659 | 20 | 28.5% |
| Food and Beverage | $35,179 | 1,112 | 21.5% |
| Travel and Lodging | $11,380 | 35 | 7.0% |
| Compensation for serving as faculty or as a speaker for a medical education program | $6,825 | 9 | 4.2% |
| Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program | $2,625 | 2 | 1.6% |
| Education | $50.98 | 10 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Abbott Laboratories | $106,499 | 751 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $33,523 | 147 | $0 (2024) |
| Actelion Pharmaceuticals US, Inc. | $10,849 | 57 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $5,054 | 7 | $0 (2024) |
| ABIOMED | $3,019 | 126 | $0 (2024) |
| Medtronic Vascular, Inc. | $1,418 | 26 | $0 (2019) |
| AstraZeneca Pharmaceuticals LP | $900.79 | 27 | $0 (2024) |
| Impulse Dynamics (USA) Inc. | $384.28 | 8 | $0 (2023) |
| PFIZER INC. | $304.37 | 17 | $0 (2024) |
| Boston Scientific Corporation | $237.44 | 4 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $47,061 | 211 | Abbott Laboratories ($35,357) |
| 2023 | $21,092 | 186 | Abbott Laboratories ($14,108) |
| 2022 | $25,855 | 242 | Abbott Laboratories ($24,559) |
| 2021 | $11,343 | 145 | Abbott Laboratories ($10,010) |
| 2020 | $9,632 | 172 | Abbott Laboratories ($9,144) |
| 2019 | $7,762 | 125 | Abbott Laboratories ($6,737) |
| 2018 | $15,743 | 81 | Novartis Pharmaceuticals Corporation ($9,532) |
| 2017 | $25,075 | 76 | Novartis Pharmaceuticals Corporation ($22,750) |
All Payment Transactions
1,238 individual payment records from CMS Open Payments — Page 1 of 50
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/31/2024 | Abbott Laboratories | CARDIOMEMS (Device) | Food and Beverage | In-kind items and services | $153.95 | General |
| Category: Heart Failure | ||||||
| 12/31/2024 | Abbott Laboratories | CARDIOMEMS (Device) | Food and Beverage | In-kind items and services | $26.85 | General |
| Category: Heart Failure | ||||||
| 12/31/2024 | Abbott Laboratories | CARDIOMEMS (Device) | Food and Beverage | In-kind items and services | $9.65 | General |
| Category: Heart Failure | ||||||
| 12/31/2024 | Abbott Laboratories | CARDIOMEMS (Device) | Food and Beverage | In-kind items and services | $5.70 | General |
| Category: Heart Failure | ||||||
| 12/18/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $22.17 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 12/18/2024 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug) | Food and Beverage | In-kind items and services | $21.58 | General |
| Category: Cardiology | ||||||
| 12/18/2024 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug) | Food and Beverage | In-kind items and services | $12.73 | General |
| Category: Cardiology | ||||||
| 12/18/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $8.18 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/16/2024 | Abbott Laboratories | CARDIOMEMS (Device) | Food and Beverage | In-kind items and services | $88.10 | General |
| Category: Heart Failure | ||||||
| 12/16/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $20.40 | General |
| Category: CARDIOVASCULAR | ||||||
| 12/16/2024 | Abbott Laboratories | CARDIOMEMS (Device) | Travel and Lodging | In-kind items and services | $16.50 | General |
| Category: Heart Failure | ||||||
| 12/11/2024 | AstraZeneca Pharmaceuticals LP | WAINUA (Drug) | Food and Beverage | In-kind items and services | $115.36 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 12/06/2024 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug), OPSUMIT | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,520.00 | General |
| Category: Cardiology | ||||||
| 12/06/2024 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug), OPSUMIT | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,520.00 | General |
| Category: Cardiology | ||||||
| 12/05/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $23.29 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/05/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $4.53 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/02/2024 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug) | Food and Beverage | In-kind items and services | $5.56 | General |
| Category: Cardiology | ||||||
| 11/29/2024 | Abbott Laboratories | THORATEC HEARTMATE 3 LVAS IMPLANT KIT (Device) | Food and Beverage | In-kind items and services | $13.24 | General |
| Category: Heart Failure | ||||||
| 11/29/2024 | Abbott Laboratories | CARDIOMEMS (Device) | Food and Beverage | In-kind items and services | $3.06 | General |
| Category: Heart Failure | ||||||
| 11/27/2024 | Abbott Laboratories | CARDIOMEMS (Device) | Food and Beverage | In-kind items and services | $24.13 | General |
| Category: Heart Failure | ||||||
| 11/27/2024 | Abbott Laboratories | CARDIOMEMS (Device) | Food and Beverage | In-kind items and services | $22.43 | General |
| Category: Heart Failure | ||||||
| 11/27/2024 | Abbott Laboratories | CARDIOMEMS (Device) | Food and Beverage | In-kind items and services | $3.06 | General |
| Category: Heart Failure | ||||||
| 11/25/2024 | Abbott Laboratories | CARDIOMEMS (Device) | Food and Beverage | In-kind items and services | $126.27 | General |
| Category: Heart Failure | ||||||
| 11/25/2024 | Abbott Laboratories | CARDIOMEMS (Device) | Food and Beverage | In-kind items and services | $24.07 | General |
| Category: Heart Failure | ||||||
| 11/25/2024 | Abbott Laboratories | CARDIOMEMS (Device) | Food and Beverage | In-kind items and services | $22.02 | General |
| Category: Heart Failure | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 21 | 1,742 | 3,032 | $734,698 | $285,011 |
| 2022 | 25 | 1,771 | 3,551 | $791,333 | $299,772 |
| 2021 | 26 | 1,831 | 3,425 | $777,398 | $298,524 |
| 2020 | 30 | 2,141 | 3,686 | $809,554 | $297,811 |
All Medicare Procedures & Services
108 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 357 | 748 | $154,088 | $70,104 | 45.5% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 180 | 638 | $128,876 | $60,363 | 46.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 200 | 333 | $92,574 | $45,272 | 48.9% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 46 | 199 | $106,266 | $33,340 | 31.4% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 180 | 227 | $89,211 | $31,023 | 34.8% |
| 93451 | Insertion of tube in right heart chambers for measurement | Facility | 2023 | 86 | 98 | $44,688 | $9,307 | 20.8% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 72 | 75 | $20,100 | $7,608 | 37.9% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 74 | 102 | $14,382 | $6,432 | 44.7% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 84 | 86 | $18,121 | $4,227 | 23.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 23 | 23 | $7,360 | $3,037 | 41.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 21 | 25 | $6,950 | $2,825 | 40.7% |
| 94621 | Test for exercise-induced heart and lung stress | Facility | 2023 | 57 | 59 | $12,272 | $2,474 | 20.2% |
| 94618 | Test for exercise-induced lung stress | Office | 2023 | 80 | 94 | $10,058 | $2,380 | 23.7% |
| 93505 | Biopsy of heart muscle | Facility | 2023 | 11 | 12 | $9,180 | $2,117 | 23.1% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 136 | 153 | $9,180 | $1,760 | 19.2% |
| 93264 | Remote monitoring of pulmonary artery pressure sensor, up to 30 days | Office | 2023 | 21 | 26 | $4,108 | $1,074 | 26.1% |
| 93308 | Ultrasound of heart, follow-up | Facility | 2023 | 38 | 54 | $4,482 | $1,067 | 23.8% |
| 99152 | Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | Facility | 2023 | 18 | 18 | $702.00 | $167.96 | 23.9% |
| 93244 | Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days | Office | 2023 | 11 | 12 | $864.00 | $154.18 | 17.8% |
| 93242 | Heart rhythm recording continous external ekg over more than 48 hours up to 7 days | Office | 2023 | 11 | 12 | $540.00 | $119.73 | 22.2% |
| 93321 | Ultrasound of heart blood flow, valves and chambers, follow-up | Facility | 2023 | 19 | 20 | $480.00 | $114.00 | 23.8% |
| 93325 | Ultrasound of heart with color-depicted blood flow, rate and valve function | Facility | 2023 | 17 | 18 | $216.00 | $44.64 | 20.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 335 | 799 | $164,594 | $74,644 | 45.4% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 197 | 876 | $176,952 | $70,295 | 39.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 158 | 255 | $70,890 | $35,161 | 49.6% |
About Dr. Jerome Thomas, MD
Dr. Jerome Thomas, MD is a Cardiovascular Disease healthcare provider based in Austin, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/13/2006. The National Provider Identifier (NPI) number assigned to this provider is 1225133689.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jerome Thomas, MD has received a total of $163,563 in payments from pharmaceutical and medical device companies, with $47,061 received in 2024. These payments were reported across 1,238 transactions from 31 companies. The most common payment nature is "Consulting Fee" ($60,844).
As a Medicare-enrolled provider, Thomas has provided services to 7,485 Medicare beneficiaries, totaling 13,694 services with total Medicare billing of $1.2M. Data is available for 4 years (2020–2023), covering 108 distinct procedure/service records.
Practice Information
- Specialty Cardiovascular Disease
- Other Specialties Cardiovascular Disease, Cardiovascular Disease
- Location Austin, TX
- Active Since 09/13/2006
- Last Updated 02/01/2022
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1225133689
Products in Payments
- CARDIOMEMS (Device) $38,968
- ENTRESTO (Drug) $33,237
- THORATEC HEARTMATE 3 LVAS IMPLANT KIT (Device) $31,503
- CardioMEMS HF System (Device) $11,083
- UPTRAVI (Drug) $10,586
- HeartMate 3 Left Ventricular Assist Device (Device) $9,204
- Adempas (Drug) $5,054
- HeartMate 3 Left Ventricular Dev (Device) $4,809
- Impella (Device) $3,019
- Ensite Cardiac Mapping System (Device) $2,647
- MITRACLIP (Device) $2,041
- Circulatory Support (Device) $1,870
- CentriMag (Device) $1,197
- HeartWare HVAD (Device) $1,168
- 2ND GEN CENTRIMAG PRIMARY CONSOLE (Device) $986.73
- BRILINTA (Drug) $647.17
- HeartMate (Device) $548.30
- OPTIMIZER (Device) $268.97
- LEQVIO (Drug) $262.17
- OPSUMIT (Drug) $221.97
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Austin
Dr. Andrea Natale, Md, MD
Cardiovascular Disease — Payments: $1.4M
Dr. Jason Zagrodzky, M.d, M.D
Cardiovascular Disease — Payments: $953,600
Dr. Rodney Horton, M.d, M.D
Cardiovascular Disease — Payments: $720,616
Francis Zidar, Md, MD
Cardiovascular Disease — Payments: $448,847
Vivek Goswami, Md, MD
Cardiovascular Disease — Payments: $338,027
Dr. Robert Canby, M.d, M.D
Cardiovascular Disease — Payments: $225,010